Gritstone Oncology Inc (GRTSQ)

Currency in USD
0.003
0.000(0.00%)
Closed·

GRTSQ Earnings

Latest Release
May 08, 2025
EPS / Forecast
-- / -0.18
Revenue / Forecast
-- / 1.70M
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
06/2025--/-0.18--/1.7M----Free Sign Up
03/2025--/-0.18--/1.7M----Free Sign Up
12/2024-0.16/-0.16921K/--0%--Free Sign Up
09/2024-0.17/-0.185--/--+8.11%--Free Sign Up
06/2024-0.16/-0.28920K/1.9M+42.86%-51.58%Free Sign Up
03/2024-0.34/-0.331.74M/1.16M-3.03%+50%Free Sign Up
12/2023-0.26/-0.2610.38M/10.38M0%0%Free Sign Up
09/2023-0.33/-0.341.57M/1.89M+2.94%-16.93%Free Sign Up
06/2023-0.31/-0.351.96M/2.51M+11.43%-21.91%Free Sign Up
03/2023-0.3/-0.342.44M/3.8M+11.76%-35.79%Free Sign Up

All numbers in USD

Gritstone Oncology Inc Earnings Call Summary for

  • GRANITE program shows positive PFS trend in colorectal cancer, with hazard ratios of 0.82 overall and 0.52 in high-risk patients
  • Q1 net loss of $40.4M; cash position of $52.8M after public offering and workforce reduction extends runway to Q4 2024
  • Mature PFS data expected Q3 2024; FDA discussions on phase three endpoints planned
  • BARDA talks ongoing for Phase 2b COVID-19 vaccine study; potential partnerships in sight
  • Company focuses on PFS improvement, particularly in low ctDNA patients; pursuing adjuvant indications for earlier stage trials
Last Updated: 11/05/2024, 15:14
Read Full Transcript
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.